Cleared Abbreviated

K001039 - THE IMPLEX HEDROCEL MODULAR ELLIPTICAL ACETABULAR CUP (FDA 510(k) Clearance)

Class II Orthopedic device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K001039 · Implex Corp. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2000
Decision
76d
Days
Class 2
Risk

K001039 is an FDA 510(k) clearance for the THE IMPLEX HEDROCEL MODULAR ELLIPTICAL ACETABULAR CUP. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Implex Corp. (Allendale, US). The FDA issued a Cleared decision on June 15, 2000 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Implex Corp. devices

Submission Details

510(k) Number K001039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 31, 2000
Decision Date June 15, 2000
Days to Decision 76 days
Submission Type Abbreviated
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
46d faster than avg
Panel avg: 122d · This submission: 76d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 558
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K001039.
G7® Revision Acetabular System
K252623 · Zimmer, Inc. · Feb 2026
Mpact 3D Metal Implants Extension – DMLS Technology
K251043 · Medacta International S.A. · Jan 2026
Velora Acetabular System
K252067 · Restor3D, Inc. · Dec 2025
TaperSet™ Hip System
K252846 · Shalby Advanced Technologies, Inc. Dba Consensus Orthopedics · Nov 2025
EMPOWR Acetabular® Liner Extension
K251833 · Encore Medical, L.P. · Nov 2025
ArTT Augments and Buttresses and Bone Screws
K251718 · Lima Corporate S.P.A. · Aug 2025